Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK
What is very clear is that two doses are required to maximise protection
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
Noosa News24 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Noosa News24 hours ago$20 million program to help women return to work
-
General20 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire
-
General20 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test